Evidence map›Paper›PMID 39726359›Full record

ArticleEmerging microbes & infections2025

To be or not to be phosphorylated: understanding the role of Ebola virus nucleoprotein in the dynamic interplay with the transcriptional activator VP30 and the host phosphatase PP2A-B56.

Lennart Kämper, Ida Kuhl, Melina Vallbracht, Thomas Hoenen, Uwe Linne, Axel Weber, Petr Chlanda, Michael Kracht, Nadine Biedenkopf

Abstract read
In one paragraph

Article in Emerging microbes & infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lennart KämperInstitute of Virology, Philipps-Universität Marburg, Marburg, Germany.ORCID 0000-0003-4624-2286
Ida KuhlInstitute of Virology, Philipps-Universität Marburg, Marburg, Germany.
Melina VallbrachtDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Thomas HoenenInstitute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald, Germany.ORCID 0000-0002-5829-6305
Uwe LinneMass Spectrometry Facility, Department of Chemistry, Philipps-Universität Marburg, Marburg, Germany.
Axel WeberRudolf Buchheim Institute of Pharmacology, Justus-Liebig University Gießen, Gießen, Germany.
Petr ChlandaDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Michael KrachtRudolf Buchheim Institute of Pharmacology, Justus-Liebig University Gießen, Gießen, Germany.
Nadine BiedenkopfInstitute of Virology, Philipps-Universität Marburg, Marburg, Germany.ORCID 0000-0002-6061-8019

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ebola virus (EBOV) transcription is essentially regulated via dynamic dephosphorylation of its viral transcription activator VP30 by the host phosphatase PP2A. The nucleoprotein NP has emerged as a third key player in the regulation of this process by recruiting both the regulatory subunit B56 of PP2A and its substrate VP30 to initiate VP30 dephosphorylation and hence viral transcription. Both binding sites are located in close proximity to each other in NP's C-terminal-disordered region. This study investigates NP's role in VP30 dephosphorylation and transcription activation, focussing on the spatial requirements of NP's binding sites. Increasing the distance between PP2A-B56 and VP30 at the NP interface revealed that close spatial and orientational contact is necessary for efficient VP30 dephosphorylation and viral transcription. Longer distances were lethal for recombinant EBOV except when a compensatory mutation, NP-T603I, occurred. This mutation, located between the NP binding sites for PP2A-B56 and VP30, fully restored functionality. Mass spectrometry showed that T603 is phosphorylated in recEBOV-NPwt virions. Mutational analysis indicated that T603I facilitates VP30 dephosphorylation in otherwise lethal recEBOV and that dynamic phosphorylation of NP-T603 is important for efficient primary viral transcription in the WT context. These findings emphasize the critical and evolutionarily pressured interplay between VP30 and PP2A-B56 within the NP C-terminal-disordered region and highlight the important role of NP on the regulation of viral transcription during the EBOV life cycle.

Indexed as

EbolavirusHemorrhagic Fever, EbolaNucleoproteinsProtein Phosphatase 2Transcription FactorsViral ProteinsBinding SitesHumansPhosphorylationProtein BindingNucleoproteinsProtein Phosphatase 2Transcription FactorsViral ProteinsVP30 protein, ebola virusEbola virushost phosphatase PP2Anucleoproteinphosphorylationregulationviral transcriptionVP30

Identifiers

PMID39726359
PMCPMC11727051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.